BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10848116)

  • 1. FDG positron emission tomography in lymphoma.
    Tecnologica MAP Suppl; 2000 Jan; ():9-10. PubMed ID: 10848116
    [No Abstract]   [Full Text] [Related]  

  • 2. FDG positron emission tomography in pancreatic cancer.
    Tecnologica MAP Suppl; 2000 Jan; ():14-6. PubMed ID: 10848118
    [No Abstract]   [Full Text] [Related]  

  • 3. FDG positron emission tomography in melanoma.
    Tecnologica MAP Suppl; 2000 Jan; ():11-3. PubMed ID: 10848117
    [No Abstract]   [Full Text] [Related]  

  • 4. FDG positron emission tomography in colorectal cancer.
    Tecnologica MAP Suppl; 2000 Jan; ():6-8. PubMed ID: 10848115
    [No Abstract]   [Full Text] [Related]  

  • 5. FDG positron emission tomography to manage patients with an occult primary carcinoma and metastasis outside the cervical lymph nodes.
    TEC Bull (Online); 2002 Jul; 19(2):14-8. PubMed ID: 12166472
    [No Abstract]   [Full Text] [Related]  

  • 6. FDG positron emission tomography in head and neck cancer.
    Tecnologica MAP Suppl; 2000 Apr; ():6-9. PubMed ID: 11010673
    [No Abstract]   [Full Text] [Related]  

  • 7. FDG positron emission tomography for evaluating breast cancer.
    TEC Bull (Online); 2003 Nov; 20(3):1-7. PubMed ID: 15043076
    [No Abstract]   [Full Text] [Related]  

  • 8. FDG PET for evaluating breast cancer.
    Tecnologica MAP Suppl; 2001 Apr; ():7-13. PubMed ID: 11718146
    [No Abstract]   [Full Text] [Related]  

  • 9. FDG positron emission tomography for the detection of ovarian cancer.
    TEC Bull (Online); 2002 Jul; 19(2):10-3. PubMed ID: 12166471
    [No Abstract]   [Full Text] [Related]  

  • 10. FDG PET in the management of lymphoma: a clinical perspective.
    Hoskin PJ
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):449-51. PubMed ID: 11914880
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care.
    Kaplan LD
    Am J Med; 2002 Mar; 112(4):320-1. PubMed ID: 11893374
    [No Abstract]   [Full Text] [Related]  

  • 12. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification.
    Tsukamoto N; Kojima M; Hasegawa M; Oriuchi N; Matsushima T; Yokohama A; Saitoh T; Handa H; Endo K; Murakami H
    Cancer; 2007 Aug; 110(3):652-9. PubMed ID: 17582800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET myocardial perfusion imaging for the detection of coronary artery disease--clinical assessment, vol. 10, no. 21, 1995.
    Tecnologica; 1996 Jan; ():7-8. PubMed ID: 10170484
    [No Abstract]   [Full Text] [Related]  

  • 14. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
    Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
    Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
    Cheson BD
    Radiol Clin North Am; 2008 Mar; 46(2):213-23, vii. PubMed ID: 18619377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG positron emission tomography for evaluating esophageal cancer.
    Tecnologica MAP Suppl; 2001 Dec; ():13-6. PubMed ID: 11933936
    [No Abstract]   [Full Text] [Related]  

  • 17. [Positron-emission tomography with fluorine-18-deoxyglucose in the staging and control of patients with lymphoma. Comparison with clinico-radiologic assessment].
    Mainolfi C; Maurea S; Varrella P; Alaia C; Imparato C; Alfano B; Abate G; Bazzicalupo L
    Radiol Med; 1998; 95(1-2):98-104. PubMed ID: 9636735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Lymphoma Therapy Using (18)F-FDG PET.
    Lowe VJ; Wiseman GA
    J Nucl Med; 2002 Aug; 43(8):1028-30. PubMed ID: 12163627
    [No Abstract]   [Full Text] [Related]  

  • 19. 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?
    Juweid ME
    J Nucl Med; 2008 Jan; 49(1):9-12. PubMed ID: 18077522
    [No Abstract]   [Full Text] [Related]  

  • 20. Positron emission tomography in the management of lymphomas.
    O'Doherty MJ; Macdonald EA; Barrington SF; Mikhaeel NG; Schey S
    Clin Oncol (R Coll Radiol); 2002 Oct; 14(5):415-26. PubMed ID: 12555882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.